HC Wainwright Analysts Increase Earnings Estimates for BEAM
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Equities research analysts at HC Wainwright boosted their Q2 2025 earnings per share estimates for shares of Beam Therapeutics in a research note issued on Wednesday, May 7th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.78) per share for the quarter, up […]
